BASKING RIDGE, N.J., April 30 /PRNewswire-FirstCall/ -- Hooper Holmes (Amex: HH) today announced the appointment of David K. Winsemius, M.D., M.P.H. as Vice President and Medical Director, and Danny Perkins, M.B.A., J.D. as Vice President of Sales, Heritage Labs.
Mark Patterson, President of Hooper Holmes' Heritage Labs division commented, "With the appointments of both Dr. Winsemius and Danny Perkins, we have enhanced the experience and insight we offer to our customers. Their backgrounds are a perfect fit for Heritage Labs; both Dr. Winsemius and Danny Perkins will assist our clients with lab and mortality related issues, provide education seminars at our clients' sites and assist with the evaluation and utilization of emerging and currently available lab tests."
Dr. David Winsemius has nearly 15 years experience as a medical director for both direct and reinsurance companies, most recently serving as VP & Medical Director for ING concentrating on brokerage underwriting and mortality analysis. He received his M.D. from the University of California, Davis, School of Medicine and his Masters of Public Health from the University of Washington School of Public Health.
Dr. Winsemius holds a number of professional certifications, including Board Certified in Insurance Medicine; Diplomat, American Board of Family Practice; Diplomat, National Board of Medical Examiners and a Certificate of Added Qualifications in Geriatrics. He currently serves as the Chair of the Mortality and Morbidity Liaison Committee for AAIM, the American Association for Insurance Medicine. He has in-depth knowledge of life and health insurance operations, insurance underwriting and geriatric medicine as well as mortality analysis of coronary artery disease, oncology, liver function tests, prostate and breast cancer and hematological conditions. He also has a deep working knowledge of multivariate statistical methods, including linear models and logistic regression.
Danny Perkins is well known in the insurance underwriting community and began his insurance career as a life underwriter in 1985. He is well-credentialed, having earned his FALU, CLU and FLMI designations. Danny also holds a Masters in Business Administration, as well as a Juris Doctor degree.
Between insurance underwriting career positions, Danny practiced law in Texas with an emphasis on probate matters and life insurance consulting. He has served on numerous professional committees including the Education Committee of the Academy of Life Underwriting, Underwriting Experience Studies Committee, Mortality and Morbidity Liaison Committee, and HOLUA Program Committee. He served as a Contributing Editor for On the Risk for seven years. Most recently Danny held the position of Vice President, Research & Development for SCOR Global Life U.S. Reinsurance Company based in Dallas, Texas.
About Hooper Holmes
Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, enabling customers to take actions that manage or reduce their risks and expenses. As the leading provider of risk assessment services for the insurance industry, Hooper Holmes provides insurers with the widest range of medical exam, data collection, laboratory testing and underwriting services in the industry.
With presence in over 250 markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the U.S. and deliver the results to its customers. Each year we arrange more medical exams than any other company and process 3.8 million specimens in our laboratory. We provide a complete service for wellness, disease management, and managed care companies including scheduling support, fulfillment of supplies, blood collection kits, medical screenings, lab testing and data transmission. We underwrite 300,000 cases annually and complete more than two million telephone interviews. We are also a leading provider of medical claims evaluation services used by property and casualty insurance carriers, law firms, self-insureds and third-party administrators to handle personal injury and accident claims.
Certain information contained herein includes information that is forward-looking. The matters referred to in forward-looking statements may be affected by the risks and uncertainties involving the Company's business. These forward-looking statements are qualified in their entirety by cautionary statements contained in the Company's Securities and Exchange Commission filings. The Company disclaims any obligation to update these forward-looking statements.
This press release contains "forward-looking" statements, as such term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements included in this press release include, without limitation, the expected reductions in expenses through productivity improvements. These forward-looking statements are based on the Company's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions. Among the important factors that could cause actual results to differ materially from those expressed in, or implied by, these forward-looking statements are our ability to successfully implement our business strategy; uncertainty as to our working capital requirements over the next 12 to 24 months; our ability to maintain compliance with the financial covenants in our credit facility; our expectations regarding our operating cash flows; and the rate of life insurance application activity. Additional information about these and other factors that could affect the Company's business is set forth in the Company's annual report on Form 10-K for the year ended December 31, 2007, filed with the Securities and Exchange Commission on March 14, 2008. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release to reflect the occurrence of unanticipated events, except as required by law.
SOURCE Hooper Holmes
